The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Double Blind Study of Melatonin Effects on the Sleep-wake Rhythm, Cognitive and Non-cognitive Functions in Alzheimer Type Dementia
Open accessAbstract
Previously, we reported that morning bright light therapy improved sleep time and cognitive function in Alzheimer type of dementia. We conducted a double blind study to examine the effects of melatonin on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type of dementia. The subjects were 9 persons given a placebo (PLA), and 11 given melatonin ( 3 mg)(MLT). The mean age was 79.2+/-6.4 (17 females and 3 males). The drugs were given at 20: 30 each day for 4 weeks. We checked sleep time and activity by Actigraph through one week before and the 4th week after drug administration. Cognitive and non-cognitive functions were evaluated with the clinical dementia rating scale (CDR), and Mini Mental State Examination (MMSE), and the Alzheimer's Disease Assessment Scale (ADAS). We successfully recorded Actigraph data from 18 patients (PLA8, MLT10). The mean sleep time change ratio and SD of the administration of PLA in the night was-0.2+/-13.7%, and MLT was 33.2+/-37.6%. The mean activity counts and SD of the administration of PLA in the night was 29.8+/-77.0%; in MLT it was-44.9+/-21.9%. Melatonin significantly prolonged the sleep time (p=0.017) and decreased activity (p=0.014) in the night (21: 00-6: 00) in the MLT group, although no significant difference in sleep time or activity in the daytime (6: 00-21: 00) was recognized between the two groups. In comparison with ADAS cognition score changes, the mean change and SD in the PLA was 0.3+/-3.7; in MLT it was-4.3+/-3.6 points. In comparison with ADAS non-cognition score, the mean change and SD in the PLA group was-0.8+/-1.0, in the MLT group it was-4.1+/-2.2 points. There were also significant differences between the PLA and the MLT groups in the comparison with the score improvement of ADAS cognition (p=0.017) and non-cognition (p=0.002), otherwise there was no significant difference in improvement of MMSE between both groups. Melatonin administration had effect to improve sleep time and night activity, but no significant effect to improve daytime naps and activity. Although melatonin administration might has less strong effect on circadian rhythm than morning bright light therapy we previously reported, cognitive and non-cognitive functions were improved. Melatonin seemed to be useful for care of the Alzheimer type of dementia patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Sundowning and Circadian Rhythms in Alzheimer’s Disease
Volicer, L., Harper, D. G., Manning, B. C., Goldstein, R., & Satlin, A. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.5.704 · Cited by 382
Circadian rhythms of melatonin and cortisol in aging
Sharma, M., Palacios-Bois, J., Schwartz, G., Iskandar, H., Thakur, M., Quirion, R., & Nair, N. P. V. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90178-9 · Cited by 260
Cited by
Morgenthaler, T., Alessi, C., Friedman, L., Owens, J., Kapur, V., Boehlecke, B., Brown, T., Chesson, A., Coleman, J., Lee-Chiong, T., et al. (2007) · Sleep · doi:10.1093/sleep/30.4.519 · Cited by 1,142
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
Fardet, A. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000041 · Cited by 1,030
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875
Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways
PANDIPERUMAL, S., TRAKHT, I., SRINIVASAN, V, SPENCE, D., MAESTRONI, G., ZISAPEL, N., & CARDINALI, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.001 · Cited by 791
Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.
Reiter, R. J., Tan, D.-X., Mayo, J. C., Sainz, R. M., Leon, J., & Czarnocki, Z. (2003) · Acta Biochimica Polonica · doi:10.18388/abp.2003_3637 · Cited by 621
Peter-Derex, L., Yammine, P., Bastuji, H., & Croisile, B. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.03.007 · Cited by 453
'The clocks that time us'—circadian rhythms in neurodegenerative disorders
Videnovic, A., Lazar, A. S., Barker, R. A., & Overeem, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.206 · Cited by 373
Melatonin and sleep in aging population
Pandi-Perumal, S. R., Zisapel, N., Srinivasan, V., & Cardinali, D. P. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.08.009 · Cited by 369
Bioactive compounds in wine: Resveratrol, hydroxytyrosol and melatonin: A review
Fernández-Mar, M. I., Mateos, R., García-Parrilla, M. C., Puertas, B., & Cantos-Villar, E. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2011.08.023 · Cited by 347
Pandi-Perumal, S. R., BaHammam, A. S., Brown, G. M., Spence, D. W., Bharti, V. K., Kaur, C., Hardeland, R., & Cardinali, D. P. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9337-4 · Cited by 320
Samsel, A., & Seneff, S. (2013) · Entropy · doi:10.3390/e15041416 · Cited by 293
Wu, Y.-H., & Swaab, D. F. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.11.010 · Cited by 279
Circadian rhythms in neurodegenerative disorders
Nassan, M., & Videnovic, A. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00577-7 · Cited by 253
Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging
Ferrari, C. K. B. (2004) · Biogerontology · doi:10.1007/s10522-004-2566-z · Cited by 227
Tan, D., Xu, B., Zhou, X., & Reiter, R. (2018) · Molecules · doi:10.3390/molecules23020301 · Cited by 220
Herring, W. J., Ceesay, P., Snyder, E., Bliwise, D., Budd, K., Hutzelmann, J., Stevens, J., Lines, C., & Michelson, D. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12035 · Cited by 185
Possible therapeutic value of melatonin in mild cognitive impairment: A retrospective study
Furio, A. M., Brusco, L. I., & Cardinali, D. P. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00491.x · Cited by 167
Circadian disruption and human health: A bidirectional relationship
Abbott, S. M., Malkani, R. G., & Zee, P. C. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14298 · Cited by 161
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
Chen, D., Zhang, T., & Lee, T. H. (2020) · Biomolecules · doi:10.3390/biom10081158 · Cited by 140
Pharmacotherapies for sleep disturbances in dementia
McCleery, J., & Sharpley, A. L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009178.pub4 · Cited by 128
Vural, E. M. S., van Munster, B. C., & de Rooij, S. E. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0178-0 · Cited by 92
Gorfine, T., Yeshurun, Y., & Zisapel, N. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00482.x · Cited by 42
Sleep in Neurodegenerative Disorders
Malkani, R., & Attarian, H. (2015) · Current Sleep Medicine Reports · doi:10.1007/s40675-015-0016-x · Cited by 12
Metadata
- Authors
- Asayama, K., Yamadera, H., Ito, T., Suzuki, H., Kudo, Y., & Endo, S.
- Venue
- Journal of Nippon Medical School
- Published
- 2003
- Volume
- 70
- Issue
- 4
- Pages
- 334-341
- ISSN
- 0048-0444 (ISSN-L)
- 1345-4676
- 1347-3409
- OpenAlex
- W2158498152
- Cited by
- 241
- References
- 3
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.